ACAD
ACADIA Pharmaceuticals Inc
Price:  
24.01 
USD
Volume:  
2,446,466.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Acadia Relative Valuation

-141.0%
Upside

As of 2024-03-02, the Relative Valuation of ACADIA Pharmaceuticals Inc (ACAD) is (9.85) USD. This relative valuation is based on P/E multiples. With the latest stock price at 24.01 USD, the upside of ACADIA Pharmaceuticals Inc based on Relative Valuation is -141.0%.

The range of the Relative Valuation is (9.66) - (9.56) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 25.9x - 30.1x 28.5x
Forward P/E multiples 22.1x - 25.6x 24.2x
Fair Price (9.66) - (9.56) (9.85)
Upside -140.2% - -139.8% -141.0%
24.01 USD
Stock Price
(9.85) USD
Fair Price

Acadia Relative Valuation - Historical P/E Data

Date P/E
2024-03-01 -64.30
2024-02-29 -62.24
2024-02-28 -63.59
2024-02-27 -70.60
2024-02-26 -69.36
2024-02-23 -66.37
2024-02-22 -66.55
2024-02-21 -66.61
2024-02-20 -66.55
2024-02-16 -67.25
2024-02-15 -67.44
2024-02-14 -68.45
2024-02-13 -68.45
2024-02-12 -71.67
2024-02-09 -70.60
2024-02-08 -68.78
2024-02-07 -67.52
2024-02-06 -68.94
2024-02-05 -67.22
2024-02-02 -67.73
2024-02-01 -70.01
2024-01-31 -69.39
2024-01-30 -71.86
2024-01-29 -73.76
2024-01-26 -72.15
2024-01-25 -72.77
2024-01-24 -72.82
2024-01-23 -75.39
2024-01-22 -74.35
2024-01-19 -73.09
2024-01-18 -73.89
2024-01-17 -74.94
2024-01-16 -77.53
2024-01-12 -76.94
2024-01-11 -77.13
2024-01-10 -78.47
2024-01-09 -82.11
2024-01-08 -80.69
2024-01-05 -81.23
2024-01-04 -80.21
2024-01-03 -79.19
2024-01-02 -82.65
2023-12-29 -83.85
2023-12-28 -84.05
2023-12-27 -85.09
2023-12-26 -83.36
2023-12-22 -84.09
2023-12-21 -79.06
2023-12-20 -77.80
2023-12-19 -80.69